Patritumab MMAE Antibody
Patritumab-MMAE is an antibody-drug conjugate (ADC) targeting ERBB3/HER3, produced in CHO cells with a huIgG1/kappa structure and ~150 kDa MW. It is utilized in oncology research for investigating targeted cancer therapies in both in vitro and in vivo experimental models.
Product Specifications
Target
HER
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
248635-ML405 100 µL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
orb1593292 100 µL
Synaptophysin Recombinant Rabbit mAb, Bio conjugated
Sign In for Pricing
View Details